Diana Ernst, RPh

Most Recent Articles by Diana Ernst, RPh

Adacel Approved for Repeat Vaccination Against Tetanus, Diphtheria, Pertussis

Adacel Approved for Repeat Vaccination Against Tetanus, Diphtheria, Pertussis

By

The approval was based on data from the Td537 study which included individuals 18-64 years old who had received a dose of Adacel 8-12 years prior (N=1330).

Supply Updates Announced for Recombivax HBV Vaccines

Supply Updates Announced for Recombivax HBV Vaccines

By

The information, posted to the Food and Drug Administration (FDA) website, states that both the Recombivax HB adult (10mcg/mL) and dialysis (40mcg/mL) formulations are not expected to be available in 2019.

SGLT2 Inhibitors and Urinary Tract Infections: What's the Link?

SGLT2 Inhibitors and Urinary Tract Infections: What's the Link?

By

For this study, the authors identified randomized controlled trials that compared SGLT2 inhibitors with placebo, no treatment, or another antidiabetic agent and reported on UTI outcome.

FDA Approves New Treatment for Travelers' Diarrhea

FDA Approves New Treatment for Travelers' Diarrhea

By

Aemcolo is a broad spectrum, semi-synthetic, orally-administered, minimally-absorbed antibiotic designed to allow for delayed release to the colon.

Afluria, Afluria Quadrivalent Approved for Use in Patients 6 Months and Older

Afluria, Afluria Quadrivalent Approved for Use in Patients 6 Months and Older

By

The vaccines are indicated for active immunization against influenza disease caused by virus subtypes A and type B present in the vaccine.

More Articles by Diana Ernst, RPh

Sign Up for Free e-newsletters